Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US16973471Application Date: 2019-06-18
-
Publication No.: US12076352B2Publication Date: 2024-09-03
- Inventor: Christiane Marie-Paule Simone Jeanne Feron , Sandra Giannini
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/EP2019/065974 2019.06.18
- International Announcement: WO2019/243307A 2019.12.26
- Date entered country: 2020-12-09
- Main IPC: A61K35/76
- IPC: A61K35/76 ; C12N7/00

Abstract:
The present invention discloses an engineered bacteriophage capable of binding to a commensal bacterium and inserting its genome polynucleotide into the commensal bacterium, but incapable of producing progeny, incapable of carrying out a lysogenic cycle and incapable of carrying out a lytic cycle within the commensal bacterium, wherein the engineered bacteriophage comprises a genome polynucleotide including at least one gene encoding at least one heterologous antigen(s) under the control of a promoter.
Public/Granted literature
- US20210252081A1 IMMUNOGENIC COMPOSITION Public/Granted day:2021-08-19
Information query